These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9580859)

  • 1. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease.
    Shreve PD
    Eur J Nucl Med; 1998 Mar; 25(3):259-64. PubMed ID: 9580859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose for the differentiation of chronic pancreatitis and pancreatic cancer.
    Imdahl A; Nitzsche E; Krautmann F; Högerle S; Boos S; Einert A; Sontheimer J; Farthmann EH
    Br J Surg; 1999 Feb; 86(2):194-9. PubMed ID: 10100786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of fluorodeoxyglucose positron emission tomography (FDG-PET) in differentiation of pancreatic lesions].
    Voth M; Opfermann T; Gottschild D
    Zentralbl Chir; 2003 May; 128(5):375-8. PubMed ID: 12813634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?
    Nitzsche EU; Hoegerle S; Mix M; Brink I; Otte A; Moser E; Imdahl A
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):237-42. PubMed ID: 11926386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation.
    Stollfuss JC; Glatting G; Friess H; Kocher F; Berger HG; Reske SN
    Radiology; 1995 May; 195(2):339-44. PubMed ID: 7724750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography.
    Friess H; Langhans J; Ebert M; Beger HG; Stollfuss J; Reske SN; Büchler MW
    Gut; 1995 May; 36(5):771-7. PubMed ID: 7797130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluorodeoxyglucose positron emission tomography (FDG-PET) in the differential diagnosis of pancreatic lesions].
    Zimny M; Schumpelick V
    Chirurg; 2001 Sep; 72(9):989-94. PubMed ID: 11594284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography.
    Ozaki Y; Oguchi K; Hamano H; Arakura N; Muraki T; Kiyosawa K; Momose M; Kadoya M; Miyata K; Aizawa T; Kawa S
    J Gastroenterol; 2008; 43(2):144-51. PubMed ID: 18306988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.
    van Kouwen MC; Jansen JB; van Goor H; de Castro S; Oyen WJ; Drenth JP
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):399-404. PubMed ID: 15549297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging findings of immune checkpoint inhibitor associated pancreatitis.
    Das JP; Postow MA; Friedman CF; Do RK; Halpenny DF
    Eur J Radiol; 2020 Oct; 131():109250. PubMed ID: 32905952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET evaluation of indeterminate pancreatic masses.
    Ho CL; Dehdashti F; Griffeth LK; Buse PE; Balfe DM; Siegel BA
    J Comput Assist Tomogr; 1996; 20(3):363-9. PubMed ID: 8626891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Cancer Complicated by Pancreatitis Demonstrated on FDG PET/CT.
    Hennessy G; Vamadevan S; Loh H; Bui C; Le K; Mansberg R
    Clin Nucl Med; 2017 Mar; 42(3):239-240. PubMed ID: 28098664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of pancreatic masses with positron emission tomography using 18F-fluorodeoxyglucose: diagnostic limitations.
    Sendler A; Avril N; Helmberger H; Stollfuss J; Weber W; Bengel F; Schwaiger M; Roder JD; Siewert JR
    World J Surg; 2000 Sep; 24(9):1121-9. PubMed ID: 11036292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermetabolic lesions of the pancreas on FDG PET/CT.
    Dong A; Dong H; Zhang L; Zuo C
    Clin Nucl Med; 2013 Sep; 38(9):e354-66. PubMed ID: 23486316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.
    Bares R; Klever P; Hauptmann S; Hellwig D; Fass J; Cremerius U; Schumpelick V; Mittermayer C; Büll U
    Radiology; 1994 Jul; 192(1):79-86. PubMed ID: 8208970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of positron emission tomography with fluorine-18 labeled fluorodeoxyglucose in differential diagnosis and staging of pancreatic carcinoma].
    Bares R; Dohmen BM; Cremerius U; Fass J; Teusch M; Büll U
    Radiologe; 1996 May; 36(5):435-40. PubMed ID: 8778929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluorodeoxyglucose positron emission tomography features of idiopathic retroperitoneal fibrosis.
    Nakajo M; Jinnouchi S; Tanabe H; Tateno R; Nakajo M
    J Comput Assist Tomogr; 2007; 31(4):539-43. PubMed ID: 17882028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.